Y-mAbs Therapeutics, Inc. (YMAB)

Y-mAbs Therapeutics Statistics

Total Valuation

YMAB has a market cap or net worth of $184.04 million. The enterprise value is $109.48 million.

Market Cap	184.04M
Enterprise Value	109.48M

Important Dates

The next confirmed earnings date is Tuesday, May 13, 2025, before market open.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

YMAB has 45.22 million shares outstanding. The number of shares has increased by 1.57% in one year.

Current Share Class	45.22M
Shares Outstanding	45.22M
Shares Change (YoY)	+1.57%
Shares Change (QoQ)	+0.56%
Owned by Insiders (%)	1.19%
Owned by Institutions (%)	47.88%
Float	27.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.97
Forward PS	1.84
PB Ratio	1.90
P/TBV Ratio	1.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.16, with a Debt / Equity ratio of 0.01.

Current Ratio	4.16
Quick Ratio	3.67
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -30.74% and return on invested capital (ROIC) is -16.08%.

Return on Equity (ROE)	-30.74%
Return on Assets (ROA)	-12.67%
Return on Invested Capital (ROIC)	-16.08%
Return on Capital Employed (ROCE)	-26.10%
Revenue Per Employee	$843,125
Profits Per Employee	-$285,250
Employee Count	104
Asset Turnover	0.71
Inventory Turnover	2.48

Taxes

Income Tax	-146,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.86% in the last 52 weeks. The beta is 0.52, so YMAB's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	-66.86%
50-Day Moving Average	4.59
200-Day Moving Average	9.31
Relative Strength Index (RSI)	44.52
Average Volume (20 Days)	212,845

Short Selling Information

The latest short interest is 3.09 million, so 6.83% of the outstanding shares have been sold short.

Short Interest	3.09M
Short Previous Month	3.07M
Short % of Shares Out	6.83%
Short % of Float	11.07%
Short Ratio (days to cover)	11.61

Income Statement

In the last 12 months, YMAB had revenue of $87.69 million and -$29.67 million in losses. Loss per share was -$0.67.

Revenue	87.69M
Gross Profit	72.43M
Operating Income	-25.11M
Pretax Income	-23.97M
Net Income	-29.67M
EBITDA	-24.58M
EBIT	-25.11M
Loss Per Share	-$0.67

Balance Sheet

The company has $67.23 million in cash and $820,000 in debt, giving a net cash position of $66.41 million or $1.47 per share.

Cash & Cash Equivalents	67.23M
Total Debt	820,000
Net Cash	66.41M
Net Cash Per Share	$1.47
Equity (Book Value)	92.00M
Book Value Per Share	2.05
Working Capital	74.81M

Cash Flow

Operating Cash Flow	-15.71M
Capital Expenditures	n/a
Free Cash Flow	-15.71M
FCF Per Share	-$0.35

Margins

Gross margin is 82.61%, with operating and profit margins of -28.64% and -33.83%.

Gross Margin	82.61%
Operating Margin	-28.64%
Pretax Margin	-34.00%
Profit Margin	-33.83%
EBITDA Margin	-28.03%
EBIT Margin	-28.64%
FCF Margin	n/a

Dividends & Yields

YMAB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.57%
Shareholder Yield	n/a
Earnings Yield	-16.87%
FCF Yield	-8.93%

Analyst Forecast

The average price target for YMAB is $18.73, which is 360.20% higher than the current price. The consensus rating is "Buy".

Price Target	$18.73
Price Target Difference	360.20%
Analyst Consensus	Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	9.38%
EPS Growth Forecast (5Y)	1.99%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

YMAB has an Altman Z-Score of 7.39 and a Piotroski F-Score of 2.

Altman Z-Score	7.39
Piotroski F-Score	2